AIM-listed biotech firms face crunch votes on London Stock Exchange exits Tech Redx Pharma and C4X Discovery have scheduled general meetings this week to vote on proposals for delisting from the London Stock Exchange.
Another listed company plans to quit London’s AIM market – this is why London Stock Exchange Drug company C4X Discovery has announced plans to quit the London Stock Exchange's AIM.